Protalix Biotherapeutics Inc (PLX)
Cost of Revenue
$7.76M
Quarterly · Period ending: · USD
PLX Cost of Revenue
Latest reported$7.76Mperiod ending
Latest reported$7.76Mperiod ending
PLX Quarterly Cost of Revenue ($0.00 → $7.76M)
Quarterly cost of revenue
High-resolution chart · PNG
PLX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 23,493 | |
| 152,734 | |
| 896,623 | |
| 1,611,000 | |
| 950,000 | |
| 1,070,000 | |
| 840,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |